Mechanism: In aged neurons, mitochondrial ROS activates HIF-1α/NF-κB, which increases CRF expression, creating a feedback loop that suppresses autophagy. Readout: Readout: MitoTEMPO treatment reduces mtROS, restoring autophagy flux to 85% and significantly lowering CRF levels and anxiety scores.
Hypothesis
In aged amygdala neurons, chronic corticotropin‑releasing factor (CRF) signaling not only suppresses autophagy initiation but also triggers a mitochondrial retrograde signal that reinforces CRF expression, creating a self‑sustaining loop that locks the autophagic machinery in a suppressed state.
Mechanistic Rationale
- CRF‑CRFR2 axis inhibits autophagy – CRF binds CRFR2, leading to downstream inhibition of VPS34 and upregulation of Rubicon, blocking autophagosome formation 1;2.
- Autophagy blockade causes mitochondrial damage – Defective mitophagy accumulates depolarized mitochondria, raising mitochondrial ROS (mtROS) 3.
- mtROS activates NF‑κB and HIF‑1α – Elevated mtROS stabilizes HIF‑1α and activates NF‑κB, which transcriptionally upregulates the Crf gene and Crfr2 in neurons 4.
- Positive feedback loop – Increased CRF further suppresses autophagy, worsening mitochondrial stress and mtROS production.
Novel Insight
While the literature notes CRF‑mediated autophagy suppression and stress‑induced inflammation, it does not connect the resulting mitochondrial ROS to a transcriptional boost of the CRF system itself. This retrograde signaling provides a mechanistic explanation for why autophagy suppression persists rather than being a transient adaptive response.
Testable Predictions
- In aged mice, amygdala neurons will show elevated mtROS, HIF‑1α stabilization, and NF‑κB activity correlating with high CRF/CRFR2 expression and low LC3‑II/I ratio.
- Pharmacological reduction of mtROS (e.g., mitoTEMPO) or genetic knockdown of HIF‑1α will decrease CRF transcription and restore autophagic flux, even without directly targeting CRFR2.
- Conversely, overexpressing a constitutively active HIF‑1α in young neurons will mimic the aged phenotype: increased CRFR2, suppressed autophagy, and heightened anxiety‑like behavior.
Experimental Approach
- Subjects – Young (3 mo) and aged (24 mo) C57BL/6J mice; optionally CRFR2‑fl mice with amygdala‑specific Cre.
- Measurements –
- MitoSOX fluorescence for mtROS.
- Western blot for LC3‑II/I, p62, phosphorylated VPS34, Rubicon.
- HIF‑1α and NF‑κB p65 nuclear levels.
- qPCR and immunohistochemistry for Crf and Crfr2.
- Behavioral assay (elevated plus maze) for anxiety.
- Interventions –
- Acute mitoTEMPO (10 mg/kg, i.p.) or vehicle.
- AAV‑shHIF‑1α vs. AAV‑HIF‑1α‑CA (constitutively active) injected into basal amygdala.
- CRFR2 antagonist (e.g., anti‑CRFR2 antibody) as a control.
- Readouts – Changes in autophagic flux (bafilomycin A1 chase), mtROS, Crf expression, and anxiety behavior.
Falsifiability
If mitoTEMPO or HIF‑1α knockdown fails to lower CRF levels or rescue autophagy despite reducing mtROS, the proposed retrograde loop would be refuted. Likewise, if HIF‑1α activation in young neurons does not increase Crf transcription or suppress autophagy, the hypothesis would not hold.
Implications
Demonstrating a CRF‑driven mitochondrial retrograde feedback would identify a druggable node (mtROS/HIF‑1α) to break the maladaptive autophagy suppression in aging, potentially alleviating stress‑related phenotypes without directly interfering with CRF signaling.
References
[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC11352966/ [2] https://www.tandfonline.com/doi/full/10.1080/07853890.2025.2490823 [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC8538758/ [4] https://pubmed.ncbi.nlm.nih.gov/23726895/
Comments
Sign in to comment.